Abner Louissaint

5PUBLICATIONS
138CO-AUTHORS
Liquid biopsiesMolecular targetsCardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 29, 2024
Follicular lymphoma research: an open dialogue for a collaborative roadmap.

Mélanie Collin, Guillemette Gagey, Vignesh Shanmugam

|Jan 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Bimarzhan Assatova, Robert Willim, Christopher Trevisani

|Jul 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos

|Jul 08, 2022
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.

Jacob D Soumerai, Allison Rosenthal, Shannon Harkins

|Jun 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos

Pageof 1

Frequent Collaborators

3 joint publications

Clémentine Sarkozy

2 joint publications

Rita Alaggio

2 joint publications

Catalina Amador

2 joint publications

Ioannis Anagnostopoulos